Denmark Active Pharmaceutical Ingredients Market Size & Outlook
Related Markets
Denmark active pharmaceutical ingredients market highlights
- The Denmark active pharmaceutical ingredients market generated a revenue of USD 2,158.3 million in 2024 and is expected to reach USD 2,870.0 million by 2030.
- The Denmark market is expected to grow at a CAGR of 4.8% from 2025 to 2030.
- In terms of segment, synthetic was the largest revenue generating type in 2024.
- Biotech is the most lucrative type segment registering the fastest growth during the forecast period.
Active pharmaceutical ingredients market data book summary
| Market revenue in 2024 | USD 2,158.3 million |
| Market revenue in 2030 | USD 2,870.0 million |
| Growth rate | 4.8% (CAGR from 2025 to 2030) |
| Largest segment | Synthetic |
| Fastest growing segment | Biotech |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biotech, Synthetic |
| Key market players worldwide | Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, AbbVie Inc, Aurobindo Pharma, Sandoz Group AG Registered Shares, Viatris Inc, Fresenius Kabi |
Other key industry trends
- In terms of revenue, Denmark accounted for 0.8% of the global active pharmaceutical ingredients market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK active pharmaceutical ingredients market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 15,561.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Active Pharmaceutical Ingredients Market Scope
Active Pharmaceutical Ingredients Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Sandoz Group AG Registered Shares | View profile | 23848 | Forum 1, Novartis Campus, Basel, Switzerland, CH-4056 | https://www.sandoz.com |
| Fresenius Kabi | View profile | 1001-5000 | Gurgaon, Haryana, India, Asia | https://www.fresenius-kabi-oncology.com/ |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| Dr. Reddy’s Laboratories | View profile | 10001+ | Hyderabad, Andhra Pradesh, India, Asia | http://www.drreddys.com/ |
| Sun Pharmaceutical Industries | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://www.sunpharma.com |
| Aurobindo Pharma | View profile | 10001+ | Hyderabad, Andhra Pradesh, India, Asia | http://aurobindo.com |
| Cipla Ltd DR | View profile | 38955 | Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 | https://www.cipla.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
Denmark active pharmaceutical ingredients market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to active pharmaceutical ingredients market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 74.65% in 2024. Horizon Databook has segmented the Denmark active pharmaceutical ingredients market based on biotech, synthetic covering the revenue growth of each sub-segment from 2018 to 2030.
Denmark’s biotech and pharma industry is one of the most innovative markets globally. It is a leader in drug development and offers attractive business solutions for international business companies.
Companies are involved in Research & Development (R&D) collaborations and several strategic alliances with research organizations & universities for faster approval or development of products in Europe. Denmark conducts the highest number of clinical trials per capita globally.
The country has over 160 biotech companies, with 40,000 people employed in this industry, of which more than 5,000 are dedicated R&D employees. There are over 300 biotech service providers, with 8 universities and 4 major university hospitals. Key players in the market include Lundbeck: Novo Nordisk; Alk-Abelló; Leo Pharma; Bavarian Nordic; and Genmab.
Reasons to subscribe to Denmark active pharmaceutical ingredients market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Denmark active pharmaceutical ingredients market databook
-
Our clientele includes a mix of active pharmaceutical ingredients market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark active pharmaceutical ingredients market , including forecasts for subscribers. This country databook contains high-level insights into Denmark active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Denmark active pharmaceutical ingredients market size, by type, 2018-2030 (US$M)
Denmark Active Pharmaceutical Ingredients Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
